ClinicalTrials.gg
Drug

Levofloxacin clinical trials

Also written Levaquin and Cravit.

studies test it
155
open now
21
in phase 3
58
first study started
1991

How each study uses Levofloxacin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Levofloxacin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
20 Dec 1996 · LEVAQUIN · NDA 020634 (FDA, Drugs@FDA)
European Union
25 Mar 2015 · Quinsair · EMEA/H/C/002789 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Levofloxacin
107
Levofloxacin 500mg
9
Amoxicillin
3
1.5% levofloxacin ophthalmic solution
3
Omeprazole
2

Brand

Levaquin
14
Cravit
3
Tavanic
2
Quixin
1
IQUIX
1

Development codes

LFX10-15
1
DIN 02284707
1
PRO-174
1
DE-108
1

In one entry with another drug

Given together, or one or the other

Doxycycline + Levofloxacin
2

Studies by the year they started

148 studies that test it; most in 2017 (14); 1 more planned to start later

Studies that test Levofloxacin, by start year
YearStudies
19911
19935
19971
19991
20001
20014
20025
20038
20049
20053
20062
20071
20083
20091
20103
20112
20126
20134
20143
20155
20166
201714
201812
20196
20203
20216
20227
20233
20245
20259
20269

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
16
Phase 2
28
Phase 3
58
Phase 4
51
No phase
18

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 43 · Other 112

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (22) · Shanghai Jiao Tong University School of Medicine (5) · National Institute of Allergy and Infectious Diseases (NIAID) (4) · Pfizer (4) · Boston University (3) · Sanofi (3) · Santen Inc. (3) · University of Manitoba (3)

Often tested with

Tested in the same studies.

Amoxicillin (14) · Linezolid (11) · Moxifloxacin (11) · Clarithromycin (10) · Bedaquiline (8) · Azithromycin (8) · Metronidazole (8) · Rifampin (7)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Levofloxacin is the comparator. A study of two new drugs counts under both.

  • 1Bedaquiline · Johns Hopkins University · next primary completion Jul 2027
Reaching primary completion within a year · 6, 2 in phase 3

Studies that test Levofloxacin, phase 3 first.

Studies

Open first, then newest update. How each study uses Levofloxacin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 155

See all 155 studies that test Levofloxacin →

Given beside what is tested · 23 — Levofloxacin is usual care or a partner of the new treatment

Showing 20 of 23.

As the comparator · 35 — what is tested is compared with Levofloxacin

Showing 20 of 35.

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call Levofloxacin · ClinicalTrials.gg INT008972

  • MeSH (NLM) D064704LevofloxacinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 6GNT3Y5LMFLEVOFLOXACINConfirmed FDA, NLM, Wikidata
  • RxNorm 82122Confirmed FDA, Wikidata
  • Wikidata Q47495791levofloxacin hemihydrateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1586LevofloxacinConfirmed FDA, Wikidata

Also registered as levofloxacin anhydrous (UNII RIX4E89Y14 · RxNorm 1546009).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.